Actively Recruiting
Study of Safety, Tolerability, and Pharmacokinetics of Grammidin Metered Dose Topical Spray Compared to Grammidin Neo Lozenges in Healthy Adults
Led by Valenta Pharm JSC · Updated on 2025-07-10
24
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, tolerability, and how the body processes Grammidin, a metered dose topical spray, compared to Grammidin lozenges after a single dose in healthy adults. This Phase 1 trial focuses on healthy volunteers aged 18 to 45 years to better understand the pharmacokinetic profile of these formulations. Participants will receive either Grammidin neo lozenges or Grammidin spray in a randomized sequence, with one group taking lozenges followed by spray and the other group receiving spray followed by lozenges. The treatments are administered once under fed conditions to assess differences between the two forms. During the study, volunteers will undergo various assessments including physical exams, vital signs, blood and urine tests, ECGs, and monitoring for adverse events from screening through 15 days after dosing. Researchers will measure pharmacokinetic parameters such as peak concentration, time to peak, area under the curve, and elimination rate to evaluate drug absorption and clearance. Safety and tolerability will be closely monitored throughout the trial period.
CONDITIONS
Brief Title
Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical Spray in Healthy Volunteers
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here